¼ÛÀÇ¿¬

  • Áø·á°ú

    ³»ºÐºñ³»°ú

  • Àü¹®Áø·áºÐ¾ß

    °©»ó¼±Áúȯ, ³»ºÐºñÁúȯ (È­¿ÀÈÄ/°©»ó¼±°áÀý one-stop)

  • ´ã´çŬ¸®´Ð

    °©»ó¼±Å¬¸®´Ð

  • °ü·Ã¼¾ÅÍ

    ´ç´¢¼¾ÅÍ

¼ÛÀÇ¿¬

¼ÛÀÇ¿¬ ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
³»ºÐºñ³»°ú
¿ÀÈÄ
Á¾ÀÏ
-
Á¾ÀÏ
- - °©»ó¼±Áúȯ, ³»ºÐºñÁúȯ (È­¿ÀÈÄ/°©»ó¼±°áÀý one-stop)

¼ÛÀÇ¿¬ ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  •  ~  2013 .02  :  Áß¾Ó´ëÇб³ Àǰú´ëÇÐ Çлç
  •  ~  2018 .02  :  ¿ï»ê´ëÇб³ Àǰú´ëÇпø ¼®»ç

°æ·Â

more
  • 2013 .03  ~  2014 .02  :  ¼­¿ï¾Æ»êº´¿ø ÀÎÅÏ
  • 2014 .03  ~  2018 .02  :  ¼­¿ï¾Æ»êº´¿ø ³»°ú ·¹Áö´øÆ®
  • 2018 .03  ~  2020 .02  :  ¼­¿ï¾Æ»êº´¿ø ³»ºÐºñ³»°ú ÀÓ»ó°­»ç

¼ö»ó³»¿ª

more
  • 2019  :  ´ëÇѳ»ºÐºñÇÐȸ Ãß°è´ëȸ ¿ì¼ö¿¬Á¦»ó
  • 2019  :  ´ëÇѰ©»ó¼±ÇÐȸ Ãß°è´ëȸ ¿ì¼ö¿¬Á¦»ó
  • 2019  :  Asia and Oceania Thyroid Association Young Investigator Award
  • 2019  :  ´ëÇѳ»ºÐºñÇÐȸ Ãá°è´ëȸ Best Oral Award
  • 2018  :  ´ëÇѳ»ºÐºñÇÐȸ Ãß°è´ëȸ ¿ì¼ö±¸¿¬»ó

ÇÐȸȰµ¿

more
  •  ~   :  ´ëÇѳ»°úÇÐȸ Á¤È¸¿ø
  •  ~   :  ´ëÇѳ»ºÐºñÇÐȸ Á¤È¸¿ø
  •  ~   :  ´ëÇѰ©»ó¼±ÇÐȸ Á¤È¸¿ø
  •  ~   :  ´ëÇÑ´ç´¢º´ÇÐȸ Á¤È¸¿ø

³í¹®

more
  • (Mutational status of advanced thyroid cancers in relationship with distant metastasis)
  • (Lenvatinib for radioactive iodine-refractory differentiated thyroid carcinoma and biomarkers with prognostic value for survival: A multicenter study in Korea)
  • (Estimating the growth rate of lung metastases in differentiated thyroid carcinoma: Response Evaluation Criteria in Solid Tumors or doubling time?)
  • (Modified Risk Stratification based on Cervical Lymph Node Metastases Following Lobectomy for Papillary Thyroid Carcinoma)
  • (Clinical significance of gross invasion of strap muscles in patients with 1–4 cm sized papillary thyroid carcinoma undergoing lobectomy)
  • (Sex-Dependent Association between Weight Change and Thyroid Dysfunction: Population-Level Analysis Using the Korean National Health and Nutrition Examination Survey)
  • (A Relook at the T Stage of Differentiated Thyroid Carcinoma with a Focus on Gross Extrathyroidal Extension)
  • (The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma)
  • (Time trends of thyroglobulin antibody in ablated papillary thyroid carcinoma patients: Can we predict the rate of negative conversion?)
  • (Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence)
  • (Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?)
  • (Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma)

ÃÖÁ¾¼öÁ¤ÀÏ : 2020.12.31